Sylvester Comprehensive Cancer Center and Kite Pharma Test Lymphoma Immunotherapy
News
Sylvester Comprehensive Cancer Center researchers in collaboration with Kite Pharma, are currently recruiting patients for a Phase 2 clinical trial testing investigational cancer immunotherapy drug KTE-C19 for the treatment of diffuse ... Read more